Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
Titel:
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
Auteur:
Hoppe, Jordana E Kasi, Ajay S Pittman, Jessica E Jensen, Renee Thia, Lena P Robinson, Philip Tirakitsoontorn, Pornchai Ramsey, Bonnie Mall, Marcus A Taylor-Cousar, Jennifer L McKone, Edward F Tullis, Elizabeth Salinas, Danieli B Zhu, Jiaqiang Chen, Yih-Chieh Rodriguez-Romero, Violeta Sosnay, Patrick R Davies, Gwyneth
Verschenen in:
Lancet respiratory medicine
Paginering:
Jaargang 13 () nr. 3 pagina's 244-255
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license